Alif Saleh

28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today’s neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition. For more information, visit 28bio.com. Our name is a tribute to the 28 crew members of Shackleton’s Endurance expedition and what’s possible when we forge ahead with an unbreakable will to explore and understand the unknown.